Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Is there a problem with inhaled corticosteroid use in COPD?
J. Chalmers (Dundee (Angus), United Kingdom)
Virtual Congress 2020 – Airway diseases
State of the art session
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chalmers (Dundee (Angus), United Kingdom). Is there a problem with inhaled corticosteroid use in COPD?. Virtual Congress 2020 – Airway diseases
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Managing COVID-19 illness: chest radiographs support defining both prognosis and follow up.
A 51-year-old man with 10-day history of cough, fever, odynodysphagie, dyspnea and fatigue
A 21-year-old male with high grade fever intermittent with chills
Related content which might interest you:
What to use INSTEAD of inhaled corticosteroids in COPD?
Source: Eur Respir J 2014; 44: 1391-1393
Is there a problem with oral corticosteroid use in asthma?
Source: Virtual Congress 2020 – Airway diseases
Are inhaled corticosteroids increasing the “load” for some patients with COPD?
Source: Eur Respir J, 50 (4) 1701848; 10.1183/13993003.01848-2017
Knowing when to stop: inhaled corticosteroids and COPD
Source: Eur Respir J 2015; 46: 1236-1238
ERS guideline on withdrawal of inhaled corticosteroids in COPD
Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD
The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation
Source: Annual Congress 2009 - Drug effects in COPD
Inhaled corticosteroids in COPD: a case in favour
Source: Eur Respir J 2009; 34: 10-12
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
Source: Eur Respir J 2005; 26: Suppl. 49, 277s
The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Inhaled corticosteroids in COPD: the case against
Source: Eur Respir J 2009; 34: 13-16
The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
The effect of applying inhaled corticosteroids in treating cough variant asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s